title: Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome.
authors.forename: G
authors.initials: G
authors.lastname: Carlomagno
authors.forename: C
authors.initials: C
authors.lastname: Pirozzi
authors.forename: V
authors.initials: V
authors.lastname: Mercurio
authors.forename: A
authors.initials: A
authors.lastname: Ruvolo
authors.forename: S
authors.initials: S
authors.lastname: Fazio
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001599:Berberine / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D019587:Dietary Supplements; D005233:Fatty Alcohols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008148:Lovastatin / Q000627:therapeutic use; D008297:Male; D024821:Metabolic Syndrome / Q000178:diet therapy* / Q000378:metabolism / Q000473:pathology*; D008875:Middle Aged; D014664:Vasodilation; D020257:Ventricular Remodeling
chemical_list: D000924:Anticholesteremic Agents; D002316:Cardiotonic Agents; D005233:Fatty Alcohols; D001599:Berberine; C080710:policosanol; D008148:Lovastatin